rs9306160

A SNP in the RRP1B gene on chromosome 21. Its most notable genotype is T;T: 0.75x (reduced) risk for metastasis in LN-/ER+ breast cancer patients

Gene
RRP1B
Location
Chr 2143,687,681 (GRCh38)
Highest magnitude
1.3Minor
Tested on
23andMe
Minor allele frequency
23%

Genotypes

As shown in 23andMe and AncestryDNA files.

  1. C;CNot ratednormalTypical · 0.071% of people
  2. C;TGood0.75x (reduced) risk for metastasis in LN-/ER+ breast cancer patientsMinor · 1.223% of people
  3. T;TMost notableGood0.75x (reduced) risk for metastasis in LN-/ER+ breast cancer patientsMinor · 1.36% of people

On SNPedia: (C;C), (C;T), (T;T). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.

Frequency

Share of each genotype in 9 HapMap populations.

  • AverageC;C 71% C;T 23% T;T 6%
  • European ancestry (Utah)C;C 33% C;T 48% T;T 19%
  • Han Chinese (Beijing)C;C 100% C;T 0% T;T 0%
  • Japanese (Tokyo)C;C 100% C;T 0% T;T 0%
  • Yoruba (Nigeria)C;C 100% C;T 0% T;T 0%
  • African ancestry (Southwest US)C;C 67% C;T 33% T;T 0%
  • Gujarati IndianC;C 48% C;T 43% T;T 9%
  • Mexican ancestry (Los Angeles)C;C 71% C;T 27% T;T 2%
  • Maasai (Kenya)C;C 92% C;T 8% T;T 0%
  • TuscanC;C 29% C;T 51% T;T 21%

Conditions, medicines and genes

Notes

From SNPedia

Show notes, about 220 words

rs9306160, also known as Pro436Leu, is a SNP in the ribosomal RNA processing 1 homolog B RRP1B gene. In a study of 1,725 LN=/ER+ breast cancer patients, carriers of a rs9306160(T) allele showed a reduced metastasis risk compared to rs9306160(C;C) patients. This association was statistically significant for both disease-free survival (DFS) and metastasis-free survival (MFS) in multivariate analysis [DFS hazard ratio 0.75, CI: 0.60–0.94, p=0.013), MFS HR 0.70, CI: 0.54–0.91, p=0.009) and overall survival (HR 0.78, CI:0.59–1.03, p=0.082)]. This study also found that rs9306160 can be combined with an independent predictor of metastasis free survival, rs2448490, to yield an even stronger prognostic. Specifically, the risk for developing distant metastasis was about 2.5-fold lower (hazard ratio 0.40, CI: 0.24-0.68, p=0.001) for LN-/ER+ breast cancer patients who were rs2448490(A;A) and rs9306160(T) carriers compared to patients who were rs2448490(G) carriers and rs9306160(C;C). Note: the allele frequencies shown in the SNPedia-associated graphic are auto-generated from data that are likely to be incorrect. In the survey of 1,863 breast cancer cases cited the authors noted a frequency of 42.5% for rs9306160(T). This is likely to be close to the frequency in the general population.

Source and license

Adapted from rs9306160 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.

SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.